Skip to main content

Author: Bill Snyder

VUMC joins national effort to improve disease prediction in diverse populations

Jun. 16, 2021—Vanderbilt University Medical Center will participate in a new federal initiative aimed at improving the use of polygenic risk scores (PRS) to predict complex diseases in diverse populations.

Read more


VUMC team develops potential treatment for life-threatening microbial inflammation

Jun. 8, 2021—A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections.

Read more


VUMC team discovers new genetic disease

Jun. 3, 2021—Researchers at Vanderbilt University Medical Center have discovered a new genetic disease that causes a severe form of neurogenic orthostatic hypotension, a rapid drop in blood pressure upon standing that can cause fainting.

Read more


VUMC researchers receive grant from the National Heart, Lung, and Blood Institute to develop biomarkers to improve the diagnosis of acute heart failure

May. 26, 2021—Researchers at Vanderbilt University Medical Center (VUMC) have received a four-year, $6.2-million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to develop a novel panel of biomarkers to improve the diagnosis of acute heart failure (AHF).

Read more


Therapeutic antibodies for hantavirus

May. 24, 2021—Vanderbilt Vaccine Center researchers have isolated monoclonal antibodies against hantaviruses, an emerging source of human disease with pandemic potential.

Read more


New clue to lung scarring

May. 20, 2021—Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases.

Read more


Nominations sought for Vanderbilt Prize Student Scholar

May. 12, 2021—Nominations for the 2021 Vanderbilt Prize Student Scholar are now open. The deadline is June 1.

Read more


VUMC to lead national study to treat severe COVID complications

May. 6, 2021—The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

Read more


Faculty Awards honor teaching, research, clinical excellence

May. 6, 2021—The 2021 Vanderbilt University School of Medicine Faculty Awards for Excellence in Teaching, Outstanding Contributions to Research and Extraordinary Performance of Clinical Service were presented April 30 during the annual spring faculty meeting, held virtually this year via Zoom.

Read more


Dire need to reform organ procurement rules: Karp

May. 5, 2021—A rule requiring greater accountability from organ procurement organizations (OPOs) will increase the nation’s supply of organs donated for transplantation, but it must be implemented quickly and effectively, Seth Karp, MD, director of the Vanderbilt Transplant Center, testified before Congress on Tuesday, May 4.

Read more


Genetic ancestry and hypertension risk

Apr. 29, 2021—Racial disparities in hypertension risk are due in part to genetic differences between ancestries, Vanderbilt investigators find in a study of participants in the Million Veteran Program.

Read more


Regev receives Vanderbilt Prize in Biomedical Science

Apr. 28, 2021—Aviv Regev, PhD, an internationally known computational biologist and executive vice president of Genentech Research and Early Development (gRED), is the recipient of the 2021 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more